2022
DOI: 10.1002/clt2.12133
|View full text |Cite
|
Sign up to set email alerts
|

AllergoOncology: Role of immune cells and immune proteins

Abstract: Background: Immune cells and immune proteins play a pivotal role in host responses to pathogens, allergens and cancer. Understanding the crosstalk between allergic response and cancer, immune surveillance, immunomodulation, role of immunoglobulin E (IgE)-mediated functions and help to develop novel therapeutic strategies. Allergy and oncology show two opposite scenarios: whereas immune tolerance is desired in allergy, it is detrimental in cancer.This is an open access article under the terms of the Creative Co… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 177 publications
0
3
0
Order By: Relevance
“…TNF-α can stimulate the proliferation of B cells, promote the secretion of Ig, and promote the release of inflammatory factors. TNF-α can affect the body's anti-infection ability, and the more severe the viral infection or bacterial infection, the higher the level of TNF-α [33,34].…”
Section: Computational and Mathematical Methods In Medicinementioning
confidence: 99%
“…TNF-α can stimulate the proliferation of B cells, promote the secretion of Ig, and promote the release of inflammatory factors. TNF-α can affect the body's anti-infection ability, and the more severe the viral infection or bacterial infection, the higher the level of TNF-α [33,34].…”
Section: Computational and Mathematical Methods In Medicinementioning
confidence: 99%
“…Although still controversial, most studies point out an antitumorigenic role of eosinophils mediated by α-defensins, TNFα, granzyme A, and IL-18, while in a few others, they are innocent bystanders or their presence in the tumor microenvironment have been linked to poor prognosis. 2,3 Furthermore, eosinophils have been proposed to be potential end-stage effector cells in cancer immunotherapy. 3 Biological agents which antagonize IL-5 or IL-5R may lead to a reduction in peripheral blood eosinophil counts.…”
Section: Real-worldevidenceontheriskofcancerwithanti-il-5and Anti-il-...mentioning
confidence: 99%
“…In laryngeal carcinoma, TGF-β regulates cells of the innate and adaptive immune system [ 45 ]. Upon exposure to TGF-β, the primary antigen-presenting cells, the dendritic cells, facilitate immune tolerance and become inactive and immobile [ 46 ]. Moreover, TGF-β skews T-naïve lymphocytes’ differentiation towards T-regulatory lymphocytes (T-regs) instead of the immune-potent Th1 lymphocytes [ 45 ].…”
Section: Epithelial-to-mesenchymal Transition (Emt)mentioning
confidence: 99%